The FDA has authorized a second Covid booster shot for people 50 and older and those 12 and older that have weakened immune systems. The decision was mostly based on data from Israel that shows it could be lifesaving for those over 60 but has only marginal benefits for younger people. Carolyn Johnson, science reporter at The Washington Post, joins us for the latest and also how the FDA will soon meet to discuss the long-term booster strategy for the rest of the population.

 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

<p>The FDA has authorized a second Covid booster shot for people 50 and older and those 12 and older that have weakened immune systems. The decision was mostly based on data from Israel that shows it could be lifesaving for those over 60 but has only marginal benefits for younger people. Carolyn Johnson, science reporter at The Washington Post, joins us for the latest and also how the FDA will soon meet to discuss the long-term booster strategy for the rest of the population.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.

Reopening America

FDA Authorizes Second Booster Shot for People 50 and Older Will Examine Long-Term Strategy Soon

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c1cce451-f34c-4740-a22f-ae6800a33bfd/transcript